ENDRA has completed a private placement to fund its foray into digital assets, immediately deploying capital into a HYPE token position that forms the cornerstone of its active treasury management.
Summary
- ENDRA Life Sciences launched a digital asset treasury and acquired $3 million in HYPE tokens.
- The move followed a $4.9 million private placement led by institutional and crypto investors.
- The HYPE token was trading around $39.30 at the time of writing, up almost 10% amid rising institutional interest.
According to one press release On October 23, the Ann Arbor-based medical technology company closed a PIPE funding round raising $4.9 million, with institutional and crypto investors leading the charge.
At the same time, the company revealed that it had allocated approximately $3 million of that capital to acquire 78,863 Hyperliquid (HYPE) tokens. ENDRA Life Sciences said the purchase represents the inaugural commitment of its newly formulated digital asset treasury, or DAT, strategy.
The company’s CEO, Alexander Tokman, stated that this move aligns the treasury with Arca Investment Management’s “highest conviction” DeFi stocks, which considers HYPE as a core asset.
“This marks a fundamental step in our long-term digital asset strategy,” Tokman said. “By joining Arca’s most strategic positions in DeFi, we’re not just preserving capital – we’re actively putting it to work in some of the most innovative and return-generating digital asset ecosystems in the world.”
ENDRA’s strategy goes beyond the initial HYPE allocation
According to the company’s strategy, the HYPE position will serve as a fundamental asset for a range of active return enhancement techniques. These include advanced options overlays, direct staking within the Hyperliquid protocol, and participation in other DeFi mechanisms.
ENDRA said the ultimate goal is to increase ‘tokens-per-share’, a new metric that reframes shareholder value in terms of direct ownership of crypto assets. This strategy aims to generate an income stream from its investments, which can be reinvested in compound growth.
The company’s entry into the Hyperliquid ecosystem coincides with a significant increase in institutional interest around the HYPE token. At the time of writing, HYPE is trading at $39.30, delivering a gain of almost 10 percent according to crypto.news data. This upward momentum appears to be fueled by major structural developments within its own ecosystem.
The price surge was particularly boosted by news that Hyperliquid Strategies, a new digital asset treasury company created from a merger involving Sonnet BioTherapeutics, has filed with the SEC to raise $1 billion. An important goal of this fundraising is to acquire HYPE tokens for its own treasury.
